Pharmacogenetics of alcohol, nicotine and drug addiction treatments: Pharmacogenetics of addiction
Open accessThe DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.
Abstract
The numerous premature deaths, medical complications and socio-economic repercussions of drug and alcohol addiction suggest that improvements in treatment strategies for addictive disorders are warranted. The use of pharmacogenetics to predict response to medication, side effects and appropriate dosages is relatively new in the field of drug addiction. However, increasing our understanding of the genetic factors influencing these processes may improve the treatment of addiction in the future. We examined the available scientific literature on pharmacogenetic advancements in the field of drug addiction with a focus on alcohol and tobacco to provide a summary of genes implicated in the effectiveness of pharmacotherapy for addiction. In addition, we reviewed pharmacogenetic research on cocaine and heroin dependence. Thus far, the most promising results were obtained for polymorphisms in the OPRM1 and CYP2A6 genes, which have been effective in predicting clinical response to naltrexone in alcoholism and nicotine replacement therapy in smoking, respectively. Opinions differ as to whether pharmacogenetic testing should be implemented in the clinic at this time because clinical utility and cost-effectiveness require further investigation. However, the data summarized in this review demonstrate that pharmacogenetic factors play a role in response to addiction pharmacotherapy and have the potential to aid in the personalization of addiction treatments. Such data may lead to improved cessation rates by allowing physicians to select medications for individuals based, at least in part, on genetic factors that predispose to treatment success or failure rather than on a trial and error basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Antidepressants for smoking cessation
Howes, S., Hartmann-Boyce, J., Livingstone-Banks, J., Hong, B., & Lindson, N. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub5 · Cited by 1,352
Picciotto, M. R., Zoli, M., Rimondini, R., Léna, C., Marubio, L. M., Pich, E. M., Fuxe, K., & Changeux, J.-P. (1998) · Nature · doi:10.1038/34413 · Cited by 1,320 · cited 2×
“…Yakel 1999). a4b2-containing nAChRs are believed to be of primary importance for mediating the rewarding effects of nicotine; both a4 and b2 subunit genes have been shown to play a role in sensitivity and response to nicotine in mice (Picciotto et al. 1998; Tapper et al. 2004; Maskos et al. 2005).”
BackgroundGrant, B. F., Hasin, D. S., Chou, S. P., Stinson, F. S., & Dawson, D. A. (2004) · Archives of General Psychiatry · doi:10.1001/archpsyc.61.11.1107 · Cited by 1,262 · cited 1×
“Alcohol and nicotine dependence are among the most prevalent addictive disorders worldwide (Kessler et al. 1997; Grant et al. 2004).”
BackgroundKoob, G. F., Sanna, P. P., & Bloom, F. E. (1998) · Neuron · doi:10.1016/s0896-6273(00)80557-7 · Cited by 1,026
Physiological Diversity of Nicotinic Acetylcholine Receptors Expressed by Vertebrate Neurons
McGehee, D. S., & Role, L. W. (1995) · Annual Review of Physiology · doi:10.1146/annurev.ph.57.030195.002513 · Cited by 1,022 · cited 2×
“However, Lerman, Schnoll & Munafo (2007) indicated that some variants associated with poor response to treatments, including Taq1A A1 and variants associated with increased CYP2A6 activity, are quite common (43% and 77% of the population, respectively).”
BackgroundNicotinic Receptors in the Development and Modulation of CNS Synapses
Role, L. W., & Berg, D. K. (1996) · Neuron · doi:10.1016/s0896-6273(00)80134-8 · Cited by 762 · cited 1×
“Nicotinic receptors are pentameric ligandgated ion channels composed of a (2–10) and b (2–4) subunits (McGehee & Role 1995; Role & Berg 1996; Gotti, Fornasari & Clementi 1997; Jones, Sudweeks & Yakel 1999). a4b2-containing nAChRs are believed to be of primary importance for mediating the rewarding…”
BackgroundNicotine Activation of α4* Receptors: Sufficient for Reward, Tolerance, and Sensitization
Tapper, A. R., McKinney, S. L., Nashmi, R., Schwarz, J., Deshpande, P., Labarca, C., Whiteaker, P., Marks, M. J., Collins, A. C., & Lester, H. A. (2004) · Science · doi:10.1126/science.1099420 · Cited by 686
Oslin, D. W., Berrettini, W., Kranzler, H. R., Pettinati, H., Gelernter, J., Volpicelli, J. R., & O'Brien, C. P. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300219 · Cited by 571 · cited 6×
“Three randomized, placebo-controlled studies (Oslin et al. 2003; Ray & Hutchison 2007; Anton et al. 2008; Kim et al. 2009) have shown that individuals with a G allele display longer abstinence and a greater reduction in the positive effects of alcohol when taking NTX.”
BackgroundInfluentialAntidepressants for smoking cessation
Hughes, J. R., Stead, L. F., & Lancaster, T. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000031.pub3 · Cited by 567
Nicotine reinforcement and cognition restored by targeted expression of nicotinic receptors
Maskos, U., Molles, B. E., Pons, S., Besson, M., Guiard, B. P., Guilloux, J.-P., Evrard, A., Cazala, P., Cormier, A., Mameli-Engvall, M., et al. (2005) · Nature · doi:10.1038/nature03694 · Cited by 566 · cited 1×
“…Yakel 1999). a4b2-containing nAChRs are believed to be of primary importance for mediating the rewarding effects of nicotine; both a4 and b2 subunit genes have been shown to play a role in sensitivity and response to nicotine in mice (Picciotto et al. 1998; Tapper et al. 2004; Maskos et al. 2005).”
Background
Cited by
Relapse prevention for addictive behaviors
Hendershot, C. S., Witkiewitz, K., George, W. H., & Marlatt, G. A. (2011) · Substance Abuse Treatment, Prevention, and Policy · doi:10.1186/1747-597x-6-17 · Cited by 467
Connor, J. P., Haber, P. S., & Hall, W. D. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00122-1 · Cited by 389
Mechanisms of Action and Persistent Neuroplasticity by Drugs of Abuse
Korpi, E. R., den Hollander, B., Farooq, U., Vashchinkina, E., Rajkumar, R., Nutt, D. J., Hyytiä, P., & Dawe, G. S. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010967 · Cited by 148
Metadata
- Authors
- Sturgess, J. E., George, T. P., Kennedy, J. L., Heinz, A., & Müller, D. J.
- Venue
- Addiction Biology
- Publisher
- Wiley
- Published
- 2011-03-01
- Volume
- 16
- Issue
- 3
- Pages
- 357-376
- ISSN
- 1355-6215 (ISSN-L)
- OpenAlex
- W1839698594
- Cited by
- 62
- References
- 21
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pharmacogenetics of alcohol, nicotine and drug addiction treatments: Pharmacogenetics of addiction. https://app.cochat.ai/papers/10.1111/j.1369-1600.2010.00287.x
- The paper
- Sturgess, J. E., George, T. P., Kennedy, J. L., Heinz, A., & Müller, D. J. (2011). Pharmacogenetics of alcohol, nicotine and drug addiction treatments: Pharmacogenetics of addiction. Addiction Biology. https://doi.org/10.1111/j.1369-1600.2010.00287.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.